Finance

Lists
TXMD:NASDAQ
TherapeuticsMD Inc
2,01 USD
-1,95%
(-0,040) 1D
5-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXMD...
Open
2,02 USD
High
2,08 USD
Low
2,01 USD
Mkt. cap
23,26 млн
Avg. vol.
27,66 миң
Volume
0,00
52-wk high
2,94 USD
52-wk low
0,99 USD
EPS
-0,02 USD
Beta
0,65
Shares outstanding
11,57 млн
No. of employees
1
Open
2,02 USD
High
2,08 USD
Low
2,01 USD
Mkt. cap
23,26 млн
Avg. vol.
27,66 миң
Volume
0,00
52-wk high
2,94 USD
52-wk low
0,99 USD
EPS
-0,02 USD
Beta
0,65
Shares outstanding
11,57 млн
No. of employees
1
News stories
From web sources and news partners
About TherapeuticsMD Inc
CEO-
Employees1
Founded1907
HeadquartersБока Ратон, Флорида, Америка Кошмо Штаттары
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
2026-ж., 11-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
869,00 миң / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
784,00 миң
893,00 миң
724,00 миң
869,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
984,00 миң
1,76 млн
836,00 миң
1,05 млн
Operating expense
1,08 млн
1,86 млн
930,00 миң
1,15 млн
Total operating expenses
1,08 млн
1,86 млн
930,00 миң
1,15 млн
Operating income
-296,00 миң
-969,00 миң
-206,00 миң
-280,00 миң
Other non operating income
381,00 миң
296,00 миң
268,00 миң
388,00 миң
EBT including unusual items
50,00 миң
-580,00 миң
103,00 миң
164,00 миң
EBT excluding unusual items
82,00 миң
-524,00 миң
103,00 миң
177,00 миң
Income tax expense
-
32,00 миң
-
-
Effective tax rate
-
-5,52%
-
-
Other operating expenses
-
-
-
-
Net income
152,00 миң
-619,00 миң
95,00 миң
155,00 миң
Net profit margin
19,39%
-69,32%
13,12%
17,84%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 миң
41,00 миң
69,00 миң
Interest expense
-3,00 миң
-
-
-
Net interest expenses
-3,00 миң
149,00 миң
41,00 миң
69,00 миң
Depreciation and amortization charges
96,00 миң
97,00 миң
94,00 миң
95,00 миң
EBITDA
-200,00 миң
-872,00 миң
-112,00 миң
-185,00 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору